Journal profile · Medicine-Urology
Progres en Urologie - FMC
ISSN 1761-676X · eISSN 2405-514X · Elsevier
Progres en Urologie - FMC: subscription journal; APC about USD 2,950; review about 41 days (submission to acceptance, publisher); 308 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Progres en Urologie - FMC is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are Urinary Bladder and Prostate Research, Prostate Cancer Diagnosis and Treatment and Ureteral procedures and complications, together about 33.6% of its articles. Its main subfields are Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Progrès en urologie-FMC est une publication périodique de 4 numéros par an. Publication officielle de l'Association Française d'Urologie, elle est consacrée à la Formation Médicale Continue et elle vient ainsi compléter Progrès en Urologie, la revue de publication de travaux originaux. Cette revue souhaite proposer aux lecteurs une mise au point faite par un expert sur un sujet précis d'actualité présenté de façon concise et très illustrée.Toute en couleur, et riche de nombreuses illustrations, elle vous offre une information de qualité avec un style direct et précis qui vous permet une lecture agréable et fluide. Les articles sont proposés par le comité de rédaction du journal mais les suggestions ou la soumission d'articles sont encouragées.Faîtes le point sur votre pratique d'aujourd'hui et découvrez celle de demain !Progrès en Urologie-FMC publie 4 numéros par an qui font référence.Journal de l'Association Française d'Urologie, Association Française des Urologues en Formation - Société Félix Guyon - Association des urologues du Québec - Société Belge d'UrologieSite Urofrance : http://www.urofrance.org/accueil.html
From the journal's Aims & Scope
Research area (LetPub): Medicine-Urology
Editor-in-chief Romain BoissierPublisher website
Editorial board by country: none in mainland China; most named France 9 (9 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Urinary Bladder and Prostate ResearchMedicine14.3%
- Prostate Cancer Diagnosis and TreatmentMedicine10.3%
- Ureteral procedures and complicationsMedicine9.1%
- Bladder and Urothelial Cancer TreatmentsMedicine8.3%
- Urological Disorders and TreatmentsMedicine7.6%
- Kidney Stones and Urolithiasis TreatmentsMedicine6.5%
- Prostate Cancer Treatment and ResearchMedicine5.9%
- Renal cell carcinoma treatmentMedicine5.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Urology | Q4 | 118/123 | 4th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.2LetPub ·
- CiteScore (publisher)
- 0.2Publisher website ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0.21LetPub ·
- h-index
- 8OpenAlex ·
- i10-index
- 5OpenAlex ·
- 2-year mean citedness
- 0.04OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 1,800 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 300 | 2 | 40 |
| 2025 | 308 | 4 | 46 |
| 2024 | 296 | 24 | 42 |
| 2023 | 233 | 10 | 27 |
| 2022 | 219 | 17 | 27 |
| 2021 | 24 | 9 | 29 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
41 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to acceptance
- 41 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,950 / EUR 2,580 / GBP 2,310 / JPY 317,030 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access
Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Model summary
All content on this site: Copyright © 2026 Elsevier B.V., its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 1761-676X
- Electronic ISSN
- 2405-514X
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Progres en Urologie - FMC
How long does peer review take at Progres en Urologie - FMC?
The publisher reports about 41 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Progres en Urologie - FMC based?
Of the 9 board members whose country the journal's board page names, none are in mainland China; the countries named most often are France (9). Counted from the institutions listed on the board page; for reference only.
Which databases index Progres en Urologie - FMC?
According to LetPub and DOAJ records, Progres en Urologie - FMC is indexed in Scopus.
Is Progres en Urologie - FMC open access, and what is the APC?
Progres en Urologie - FMC is a subscription journal. APC about USD 2,950.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .